Your browser doesn't support javascript.
loading
Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study.
Ruiz-Bañobre, J; Molina-Díaz, A; Fernández-Calvo, O; Fernández-Núñez, N; Medina-Colmenero, A; Santomé, L; Lázaro-Quintela, M; Mateos-González, M; García-Cid, N; López-López, R; Vázquez, S; Anido-Herranz, U.
Afiliação
  • Ruiz-Bañobre J; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago de Co
  • Molina-Díaz A; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
  • Fernández-Calvo O; Medical Oncology Department, Complejo Hospitalario Universitario de Ourense, Ourense, Spain.
  • Fernández-Núñez N; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain.
  • Medina-Colmenero A; Medical Oncology Department, Centro Oncológico de Galicia, A Coruña, Spain.
  • Santomé L; Medical Oncology Department, Hospital Povisa, Vigo, Spain.
  • Lázaro-Quintela M; Medical Oncology Department, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
  • Mateos-González M; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago de Co
  • García-Cid N; Medical Oncology Department, Complejo Hospitalario Universitario de Ourense, Ourense, Spain.
  • López-López R; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago de Co
  • Vázquez S; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain.
  • Anido-Herranz U; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago de Co
ESMO Open ; 6(2): 100090, 2021 04.
Article em En | MEDLINE | ID: mdl-33740735
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article